Validation of a Seizure Monitoring System

Completed

• Conditions: Epilepsy

• Registration Number: NCT03465189
• Lead Sponsor: St Vincent's Hospital Melbourne

Brief Summary

The investigators aim to determine the feasibility of using the Medtronic LINQ device for epilepsy diagnosis, monitoring and management. The feasibility will be determined by comparing EEG signals from the LINQ system to the gold standard clinical recordings. If seizures can be identified using the LINQ device with the same level of accuracy as adjacent scalp EEG recording electrodes, then the LINQ will be deemed feasible.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-03-07
• Study First Submitted QC: 2018-03-07
• Study First Posted: 2018-03-14
• Study Start: 2018-09-10
• Primary Completion: 2019-03-19
• Study Completion: 2020-03-19
• Status Verified: 2020-10
• Last Update Submitted: 2020-10-25
• Last Update Posted: 2020-10-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Patients with epilepsy

Exclusion Criteria

• Women that are pregnant
• Patients that are highly dependant on medical care
• Patients that cannot give informed consent for themselves

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Verify feasibility of using the LINQ device for epilepsy diagnosis, monitoring and management	one week	Compare EEG from traditional scalp EEG to the LINQ recordings to determine if seizure activity can be accurately identified

Trial Locations

Locations (1)

St Vincent's Hospital Melbourne; 🇦🇺 Melbourne, Victoria, Australia